Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
Journal of Neurology, Neurosurgery, and Psychiatry|January 28, 2022
Stroke imaging prior to thrombectomy in the late window: results from a pooled multicentre analysisMohammed A Almekhlafi, John Thornton, Ilaria Casetta, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 19, 2024
Workflow and Outcome of Thrombectomy in Late Time Window: A Pooled Multicenter AnalysisAyoola Ademola, Fouzi Bala, Bijoy K Menon, et al.
Eclinicalmedicine|August 25, 2020
Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare systemCian P McCarthy, Sean Murphy, Maeve Jones-O'Connor, et al.
European Stroke Journal|August 20, 2021
Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trialPeter Kelly, Christian Weimar, Robin Lemmens, et al.
Stroke|June 7, 2019
Carotid Plaque Inflammation Imaged by 18F-Fluorodeoxyglucose Positron Emission Tomography and Risk of Early Recurrent StrokePeter J Kelly, Pol Camps-Renom, Nicola Giannotti, et al.
Stroke|January 18, 2020
A Risk Score Including Carotid Plaque Inflammation and Stenosis Severity Improves Identification of Recurrent StrokePeter J Kelly, Pol Camps-Renom, Nicola Giannotti, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2025
Secondary Electron Hyperspectral Imaging of Carbons: New Insights and Good Practice GuideJames F Nohl, Nicholas T H Farr, Maria Rosaria Acocella, et al.
Neurology|April 14, 2022
Association of Plaque Inflammation With Stroke Recurrence in Patients With Unproven Benefit From Carotid RevascularizationPol Camps-Renom, John McCabe, Joan Martí-Fàbregas, et al.
Lancet (London, England)|June 10, 2024
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trialPeter Kelly, Robin Lemmens, Christian Weimar, et al.
Blood|April 24, 2020
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trialPeter M Voorhees, Jonathan L Kaufman, Jacob Laubach, et al.
Pageof 20